Discover 867 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
El Paso offers a variety of clinical research opportunities focused on conditions such as asthma, diabetes, arthritis, and Parkinson’s disease. The city’s growing healthcare sector is actively recruiting participants, providing access to cutting-edge treatments for both healthy volunteers seeking paid research studies and individuals looking for trials targeting specific health conditions.
Filter
2
Filter results
Results: 867
Active & Responsive
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Denver CO, Salt Lake City UT, Tucson AZ, Dallas TX,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05216432
Phase1, Recruiting
Active & Responsive
Device Global Registry for the IlluminOss Bone Stabilization System
for
Traumatic Fracture, Pathological Fracture
Location: Denver CO, Los Angeles CA, Katy TX, Pittsburgh PA,
Sponsor: IlluminOss Medical, Inc.
Sex: All
Age: 50+
Code: NCT05206981
Recruiting
Active & Responsive
A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
Location: Denver CO, Aurora CO, Kansas City KS, Austin TX,
Sponsor: Marker Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05798897
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Denver CO, Aurora CO, Salt Lake City UT, Lubbock TX,
Location: Denver CO, Las Vegas NV, Rochester MN, St Louis MO,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT04363684
Recruiting
Active & Responsive
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
for
Hereditary Hemorrhagic Telangiectasia,
Location: Aurora CO, Salt Lake City UT, Dallas TX, Rochester MN,
Sponsor: Cure HHT
Sex: All
Age: 0+
Code: NCT06259292
Recruiting
Active & Responsive
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
for
Glioblastoma
Location: Aurora CO, Salt Lake City UT, Minneapolis MN, Orange CA,
Sponsor: Global Coalition for Adaptive Research
Sex: All
Age: 18+
Code: NCT03970447
Phase2, Phase3, Recruiting
Active & Responsive
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
for
Eosinophilic Gastrointestinal Disorders (EGIDs),
Location: Aurora CO, Denver CO, Salt Lake City UT, Phoenix AZ,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 3+
Code: NCT02523118
Recruiting
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Location: Denver CO, Kansas City KS, Dallas TX, Los Angeles CA,
Sponsor: Anagram Therapeutics, Inc.
Sex: All
Age: 12+
Code: NCT07450547
Phase2, Recruiting
Active & Responsive
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
for
Cystic Fibrosis
Location: Denver CO, Aurora CO, Kansas City KS, Dallas TX,
Sponsor: Boston Children's Hospital
Sex: All
Age: 6+
Code: NCT06683092
Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Denver CO, Aurora CO, Kansas City MO, Gilbert AZ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase3, Recruiting
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
for
Treatment Resistant Depression
Location: Denver CO, Draper UT, Tucson AZ, Rogers AR, Plano TX,
Sponsor: atai Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06524830
Phase2, Recruiting
Active & Responsive
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)